Article
humMR1, a highly specific humanized single chain antibody for targeting EGFRvIII.
International immunopharmacology - 1 Feb 2014
Safdari Yaghoub, Farajnia Safar, Asgharzadeh Mohammad, Omidfar Kobra, Khalili Masoumeh
Abstract excerpt
Production of an efficient humanized single chain antibody is reported here to specifically target EGFRvIII, a truncated receptor expressed in a wide variety of human cancers. CDR loops of MR1, a phage display-derived murine single chain antibody developed against this mutant receptor, were grafted on human frameworks that had been selected based on similarity to MR1 in terms of two distinct parameters, variable...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
